Close Menu

After 17 years at Lilly, the head of R&D at Lilly Research Laboratories Steven Paul is retiring. While speaking with R&D Directions, Paul says his accomplishments during that time include debuting three new drugs while leading the neuroscience division, redesigning the discovery aspect of the organization, and bringing in new people to keep the pipeline moving.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

IBM security researchers warn of a phishing campaign targeted at organizations involved in the distribution of SARS-CoV-2 vaccines, the Verge reports.

The Illinois police have cut the number of DNA tests waiting to be run in about half, CBS Chicago reports.

A researcher accused of smuggling research materials out of the US has pleaded guilty to making false statements, according to the Associated Press.

In Science this week: gene expression signature linked to nonalcoholic fatty liver disease progression, and more.